{"id":199817,"name":"THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN","slug":"the-susan-g-komen-breast-cancer-foundation-inc-dba-susan-g-komen","state":"TX","country":"United States of America","description":"","totalSpending":2500000,"filings":32,"yearlySpending":[{"year":2018,"income":320000},{"year":2019,"income":330000},{"year":2020,"income":230000},{"year":2021,"income":250000},{"year":2022,"income":270000},{"year":2023,"income":300000},{"year":2024,"income":310000},{"year":2025,"income":490000}],"issues":["HCR","BUD","INS","MMM","DEF","GOV"],"firms":["THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN"],"lobbyists":["MOLLY GUTHRIE","ARACELY PANAMENO","VALERIE NAUMAN NELSON"],"govEntities":["Centers For Disease Control & Prevention (CDC)","Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE","Internal Revenue Service (IRS)","White House Office","Labor, Dept of (DOL)","Treasury, Dept of","Office of Management & Budget (OMB)","Office of Science & Technology Policy (OSTP)","Office of Personnel Management (OPM)","Vice President of the U.S.","Agency for Healthcare Research & Quality (AHRQ)","Consumer Financial Protection Bureau (CFPB)"],"sampleDescriptions":["H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients. \n\nH.R.930/S.497, Lymphe","H.R.1625 - Vehicle for Consolidated Appropriations Act 2018 - issues related to cancer prevention, screening and research funding. \n\nFY2019 Labor, Health and Human Services and Education Appropriation","H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;\n\nH.R.1676/S.693, Palliative Care and Hospice Educatio","H.R.1409, Cancer Drug Parity Act of 2017, advocate for equitable coverage of cancer therapies; \n\nH.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies;\n\nH.R.4978, Chronic","FY2019 Labor, Health and Human Services and Education Appropriations Bill - issues related to cancer prevention, screening and research funding."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}